Apex drugs regulator proposes steps to check spurious drugs

The Central Drugs Standard Control Organisation (CDSCO) plans to further tighten the screws this year on those making and selling spurious and substandard medicines, a widespread problem in India.

- Priyanka Sharma

As part of the plan, in addition to the revised schedule M good manufacturing practices (GMP) compliance, the apex drug regulator will focus on risk-based inspection, increased monitoring and sampling, and extensive sensitization and enforcement.

The plan also involves directing all states and Union territories to share spurious and substandard drugs data with the Centre.